Skip to main content
BMC Complementary and Alternative Medicine logoLink to BMC Complementary and Alternative Medicine
. 2016 Mar 8;16:93. doi: 10.1186/s12906-016-1070-8

Ethnopharmacological survey of herbal remedies used for treatment of various types of cancer and their methods of preparations in the West Bank-Palestine

Nidal Amin Jaradat 1,, Rowa Al-Ramahi 1, Abdel Naser Zaid 1, Ola Ibrahim Ayesh 1, Ahmad Mustafa Eid 1
PMCID: PMC4784411  PMID: 26955822

Abstract

Background

Plants have been the primary source of medicines since life on earth; more than 50 % of existing cancer treatments are derived from plants.

Methods

An ethnopharmacological survey of herbal remedies used in cancer treatment was carried out in the West Bank/ Palestine. A questionnaire was distributed to one hundred and fifty herbalists, traditional healers and rural dwellers. Collected information included the names of plants, the used parts, types of cancers for which these plants were used and also their methods of preparation. To identify the most important species used, Factor of informant’s consensus (Fic), Fidelity level (Fl) and the Use-value (UV) were calculated.

Results

Collected data has shown that 72 plants are utilized for treatment of cancer, belonging to 44 families; from them Compositae and Lamiaceae were the most common. Leaves and fruits were the most commonly used parts, while decoctions, infusions and syrups were the main methods of preparation. Lung cancer was the most common type of cancer treated with these plants and Ephedra alata was the most commonly used plant for treatment of cancer in Palestine. The Fic was high for all the plants; Fl was 100 % for many plants, the highest UV (0.72) was for Ephedra alata.

Conclusions

This study showed that many herbal remedies are still used by herbalists in Palestine for treatment of cancer; some of them have been approved scientifically while others are not. A combined effort between informants and scientific institutions working in this field can help in the discovery of new anticancer agents. Moreover, scientists must explore the most suitable method of extraction, formulation and dose determination in order to achieve the best benefits from these herbals.

Keywords: Ethnopharmacology, Anticancer, Herbal remedies, Traditional use, Ephedra alata

Background

The Holy Land/ Palestine has miscellaneous ethnic groups (Muslims, Christians, Druze, Jews from East and West and Samaritans), so its characteristic cultures are numerous and varied, including folkloric herbal medicine. However, these traditions in herbal remedies have waned over hundreds of years. Palestine is a unique land, in its ecological diversity due to its geographical location between Africa, Asia and Europe. Different zoogeographic, climatic, and phytogeographic zones covered Palestine, creating great biological multi-diversity [1, 2]. In addition to that it was as an important international trade crossroad from ancient times, between North Africa, East Asia and West Europe; this added to its culture in herbal medicines [35].

Plants provide a continual source of medicines for animals and humans; they have been used since ancient times in crude forms as decoctions, syrups, liniments, powders, infusions and ointments [6, 7]. Evidence of medicinal plant use around 60 000 years ago was found in a cave discovered in 1960 in the Middle East [8, 9]. In recent time, people in both developed and developing countries utilize herbal medicines for improving their health [1012]. According to the World Health Organization (WHO) evaluations, about 80 % of populations in developing countries have utilized ethno-medicines for their health care requirements and more than 60 % of cancer patients have used natural plant products with vitamins in fighting this disease [1315]. While 50 % of modern pharmaceutical medications in clinical practice are derived from plants, many of them have strong anticancer effects [16, 17].

According to the WHO and the American Cancer Society about eight million died from cancer and about fourteen million new cancer cases occurred in 2012. The highest percentages of patients were with lung, breast and colorectal cancers respectively. WHO also estimates a substantive increase up to nineteen million new cases of cancer per year by 2025, due to the growth of global population. More than half of all cancers and cancer deaths occurred in less developed countries, and these proportions may be further increased [1820].

Nowadays, chemotherapeutic anticancer agents are the most common method of treatment, but they may cause serious side effects and toxicity [2123].

Due to the high death rate among patients with cancer and the hazardous side effects and adverse reactions of the radiotherapy and chemotherapy, cancer patients often start seeking alternative methods of treatments, like herbal medicine with or instead of conventional medicine [2426].

Methods

An ethnopharmacological survey on herbal remedies used for treatment of various types of cancer was conducted from March 2015 to June 2015. Areas visited included all regions of the West Bank/Palestine; Nablus, Jenin, Tubas, Toulkarm, Salfeit, Qalqilya, Ramallah, Jericho, Jerusalem, Bethlehem and Hebron (Fig. 1).

Fig. 1.

Fig. 1

Map of the West Bank/ Palestine showing all surveyed regions

The study aims, protocols and the informed consent forms were approved by the Institutional Review Board (IRB) at An-Najah National University (IRB archived number 25/Jan/ 2015). The study was conducted in accordance with the requirements of the declarations of Helsinki.

The study was carried out by interviews with herbalists, traditional healers and rural dwellers that used herbal remedies in the treatment of different types of cancer. The number of registered herbalists in the West Bank is 222. According to the Raosoft calculator the minimum sample should be 141 participants, so we included 150 [27]. These informants represented most of the practitioners in this field in the West Bank (Sociodemographic characteristics are presented in Table 1).

Table 1.

Sociodemographic characteristics of the respondents

Variable N (%)
Gender
Male 128 (85.3)
Female 22 (14.7)
Education level
Uneducated 26 (17.3)
Elementary 14 (9.3)
Secondary school 28 (18.7)
High secondary school 53 (35.3)
Undergraduate 27 (18)
Graduate (higher education) 2 (1.3)
Residency
Bethlehem 13 (8.7)
Hebron 13 (8.7)
Jenin 21 (14.0)
Jericho 9 (6.0)
Jerusalem 10 (6.7)
Nablus 20 (13.3)
Qalqilya 7 (4.7)
Ramallah 14 (9.3)
Salfeit 18 (12.0)
Tubas 7 (4.7)
Toulkarm 18 (12.0)
Age (mean ± SD) years 54.7 (14.3)
Experience (mean ± SD) years 34.8 (14.3)

A convenience sample of herbalists and practitioners from various regions were met by researchers and asked to answer a face to face questionnaire. They were interviewed in Arabic after getting their verbal consent only once.

Statistical analyses were performed by using Statistical Package for Social Sciences (SPSSversion17.0). Mean ± standard deviation were computed for continuous data. Frequencies and percentages were calculated for categorical variables. Means were compared using Student’s t-test. Categorical variables were compared using Chi-squared and Fisher’s exact tests, as applicable. A p-value of less than 0.05 was considered to be statistically significant for all analyses.

Questionnaires were administered through personal contact discussions. This method is an effective and easy option of data collection. This survey aimed to obtain information on the names of plants commonly used in the treatment of cancer, the type of cancer treated by herbs, the methods of preparing and the parts used for administration. Interviews were conducted in the Arabic language of the informants. Names of plants were translated later to English and Latin. In most cases, the interviews often started in the form of informal discussions to gain the confidence of the interviewees.

All of the 72 plant materials were collected from the interviewees (herbalists, traditional healers and rural dwellers) and kept in special glass frames and later identified by the pharmacognosist Dr. Nidal Jaradat. The identity of each plant species mentioned by the interviewees was confirmed and verified by using photographs and live specimens. A medicinal use was accepted as valid only if it was mentioned by at least three independent herbal practitioners. Samples of these collected herbs were given a herbarium specimen number as shown in Table 2 and voucher samples were kept at the Pharmacognosy Laboratory of the Department of Pharmacy at An-Najah National University, Faculty of Medicine and Health Sciences (Table 2).

Table 2.

Medicinal plants used for treatment of cancer in the West Bank regions/Palestine

Scientific names/Common names/Arabic names/Voucher specimen code Family Part used, method of preparation (herbal formulation) and dosages Cancer Type Preparation method and administration UV
1. Allium cepa L./Onion / Basal/ Pharm-PCT-2703 Amaryllidaceae Bulb/About 20–40 ml of the bulb juice is to be given orally 7–8 times daily for four weeks. Lung and stomach Fresh bulb (oral) 0.29
2. Allium sativum L./ Garlic/Thom/ Pharm-PCT-2704 Amaryllidaceae Bulb/2–3 fresh cloves are eaten raw three times daily with meals. Lung, Esophageal and breast Fresh bulb (oral) 0.46
3. Mangifera indica L./ Mango/ Manga/ Pharm-PCT-2725 Anacardiaceae Fruits/About 300 ml of fresh fruit juice is to be given orally three times daily. Colon Fresh juice (oral) 0.09
4. Pistacia palaestina Boiss./ Mastic tree, Lentisk/ Sirees/ Pharm-PCT-1870 Anacardiaceae Leaves/Powdered leaves mixed with goat fat as paste, applied externally twice daily on cancer area. Skin Paste (topical) 0.59
5. Annona muricata L. / Soursop/ Keshta/ Pharm-PCT-2726 Annonaceae Fruit/One fresh fruit boiled with 100 ml syrup for five minutes; 20 ml of the produced syrup is to be given orally three times daily. Bladder, prostate and colon Syrup (oral) 0.32
6. Daucus guttatus Sm. / Wild Carrot/ Jazar barry/ Pharm-PCT-832 Apiaceae Seeds/About 100–130 powdered seeds steeped in water for 12 hours; 100 ml from the produced infusion is to be orally given four times daily. Skin Infusion (oral) 0.02
7. Petroselinum crispum (Mill.) Fuss/ Parsley/ Bokdonas/ Pharm-PCT-2739 Apiaceae Fruits/About 500–600 grams from the ground dry fruits boiled with one liter water for 30 minutes; 300 ml of this decoction is to be given orally three times daily. Kidney and bladder Decoction (oral) 0.16
8. Calotropis procera (Aiton) Dryand./ Apple of Sodom, (mudar)/ A’oshar basek/ Pharm-PCT-472 Apocynaceae Aerial parts (latex)/ Ten grams from air dried latex from the fruits is boiled with 40 ml water; 20 ml of this decoct is to be given twice daily. Skin Decoction (oral) 0.61
9. Catharanthus roseus (L.) G.Don/ Vinca/ Wanaky/ Pharm-PCT-2728 Apocynaceae Entire plant/About 25grams from the powdered plant mixed with 30 ml water; this paste is applied topically once daily. Skin Paste (topical) 0.47
10. Nerium oleander L./Oleander/ Dafla/ Pharm-PCT-1636 Apocynaceae Entire plant/About 20 grams from the powdered plant are mixed with 50 grams lanolin; this cream is applied topically on the skin cancer area directly 4–5 times daily. Skin Cream (topical) 0.53
11. Arum dioscoridis Sm./ Spotted arum/ loof mobarkash/ Pharm-PCT-243 Araceae Leaves/Boil about 10 grams of the dried leaves with 100 ml water, fifty ml of this decoction is to be given orally before meal. Liver and stomach Decoction (oral) 0.66
12. Arum palaestinum Boiss./ Cuckoo pint / loof/ Pharm-PCT-246 Araceae Leaves/Boil about 10 grams of the dried leaves with 150 ml water, fifty ml of this decoction is to be given orally three times daily before meals. Liver, colon, kidney and breast Decoction (oral) 0.63
13. Polygonatum multiflorum (L.) All./ David's harp / Khatem Soleyman/ Pharm-PCT-2727 Asparagaceae Rhizomes/Steep 2 grams from the powdered rhizomes with 100 ml water for 5 hours; 20 ml from this infusion is to be given orally three times daily. Liver, brain and spinal cord Infusion (oral) 0.60
14. Brassica oleracea L./Cabbage/ malfof/ Pharm-PCT-1930 Brassicaceae Leaves/100 ml from the fresh cabbage leaf juice is to be given 7–9 times daily. Liver Fresh juice (oral) 0.46
15. Sinapis arvensis L./Wild mustard/ Khardal/ Pharm-PCT-2284 Brassicaceae Seeds/Powdered seeds (2 g) given orally twice daily. Bone Powder (oral) 0.47
16. Capparis spinosa L./Caper bush/ Cobar/ Pharm-PCT-496 Capparaceae Roots/Crushed fresh roots (100 grams) mixed with 10 ml water, made into paste then applied topically once daily. Bones cancer Paste (topical) 0.47
17. Colchicum hierosolymitanum L./ Colchicum/Lohlah/Pharm-PCT-644 Colchicaceae Seeds/50 grams from the ground seeds mixed with 100 grams lanolin a are applied topically once daily on the tumor area. Skin Cream (topical) 0.53
18. Achillea aleppica DC./
Yarrow/ Kaysoom/ Pharm-PCT-16
Compositae Aerial parts/Steep 15grams from the plant with 100 ml water for 2 hours, 10 ml from this infusion is to be given internally twice daily. Liver Infusion (oral) 0.11
19. Cichorium endivia L./Common chicory/ Shokar/ Pharm-PCT-617 Compositae Flowers/Steep 100 grams from the plant with 100 ml water for 2 hours; 30 ml from this infusion is to be given once daily. Stomach and colon Infusion(oral) 0.22
20. Inula viscosa (L.) Aiton/False Yellow head/ Tayon/ Pharm-PCT-2738 Compositae Leaves/ Boil about 20 grams from the flowers with 100 ml water; 30 ml of this decoction is to be given orally three times daily before meals. Kidney and bladder Decoction (oral) 0.32
21. Matricaria aurea (Loefl.) Sch.Bip./ Golden Chamomile/Babonaj thahabi/ Pharm-PCT-1519 Compositae Flowers/ In case of lung cancer: Boil 50 grams flowers with 500 ml water; the vapor is inhaled twice daily for 10 minutes each time.
In case of liver and prostate cancers: Boil 30 grams from the flowers with 300 ml water for 15 minutes; 100 ml from the decoction is to be given orally twice daily.
Lung, liver and prostate Vapor inhalation 0.47
22. Onopordum cynarocephalum subsp./Artichoke Cotton-thistle/ kondrees/ Pharm-PCT-1692 Compositae Flowers/ Steep 50 grams of the dried flowers with 100 ml water for one night; 50 ml from this infusion is to be given three times daily. Stomach and colon Infusion (oral) 0.23
23. Silybum marianum (L.) Gaertn./Milk thistle Khorfeesh/Pharm-PCT-2282 Compositae Stalk/ 30 drops of celery stalk fresh juice is to be given orally every three hours. Colon and skin cancer Fresh juice (oral) 0.32
24. Taraxacum syriacum Boiss./ Common dandelion/Hindeba/ Pharm-PCT-2396 Compositae Leaves/ Boil about 60 grams from the dried powdered plant with 100 ml water for 15 minutes; entire decoction is to be given 3–5 times daily. Pancreatic and gallbladder stomach Decoction (oral) 0.35
25. Citrullus colocynthis (L.) Schrad./ Bitter Gourd/Hanthal/Pharm-PCT-628 Cucurbitaceae Fruits/ About 150 grams from the powdered dried fruits mixed with equal quantity of lanolin; the produced cream applied topically twice daily. Skin Cream (topical) 0.13
26. Cucumis sativus L./cucumber/ kheyar/ Pharm-PCT-2737 Cucurbitaceae Seeds/ Steep 4grams of the ground seeds with 100 ml water for 12 hours; 10 ml from this infusion is to be given three times daily Colon Infusion (oral) 0.07
27. Ecballium elaterium (L.) A.Rich./ Exploding cucumber / Ketha’ alhemar/ Pharm-PCT-870 Cucurbitaceae Fruits (juice)/ / One fresh fruit pulp (about 25gram) juice is to be orally given five times daily Throat and liver Fresh juice (oral) 0.17
28. Ephedra alata Decne./ Ephedra/ Alanda/ Pharm-PCT-904 Ephedraceae Entire plant/ About 100 grams of the powdered plant boiled with 500 ml water for 5 minutes; 100 ml of this decoction is to be given orally twice a day. Brain, liver and colon Decoction (oral) 0.72
29. Arbutus andrachne L./Greek Strawberry Tree/ Kotlob/ Pharm-PCT-213 Ericaceae Fruits/ Boil 50 grams of the ground fruits with 100 ml water and 100 gram sugar; 20 ml of the produced syrup is to be given orally 5–6 times daily. Stomach Syrup (oral) 0.06
30. Euphorbia hierosolymitana Boiss./ Spurge/Halablabon/Pharm-PCT-988 Euphorbiaceae Entire plant/ Boil 50 grams from the plant with 150 ml water for 10 minutes; 5 ml of this decoction is to be given each 8 hours. Ovarian, breast and prostate Decoction (oral) 0.59
31. Quercus calliprinos Webb/ Palestine oak/ Baloot/ Pharm-PCT-1978 Fagaceae Fruits/ Boil about 20 grams from the fruits with 100 ml water, 20 ml of this decoction is to be given four times daily. Colorectal Decoction (oral) 0.11
32. Quercus ithaburensis Decne./ Valonia oak/Sendnyan/ Pharm-PCT-1980 Fagaceae Bark/ Mix 30 grams of the powdered bark with 100 ml lanolin then apply this cream on the cancer area. Skin Cream (topical) 0.13
33. Hypericum perforatum L./St.John’s Wort/ Oshbat ala’ran/Pharm-PCT-2734 Hypericaceae Flowers/ About 100 grams of the powdered flowers with 100 ml olive oil then filtered and 20 ml of the produced infusion is to be given orally twice daily. Brain Infused in olive oil (oral) 0.05
34. Crocus sativus L./ Saffron/ Za’faran/ Pharm-PCT-2733 Iridaceae Flowers/ Two grams of Saffron powder steeped in 300 ml camel milk; this milk infusion is to be given early morning once daily. Liver and kidney Infusion (oral) 0.46
35. Melissa officinalis L./Balm mint/ Torenjan/ Pharm-PCT-1564 Lamiaceae Aerial parts/ About 10 grams of the fresh leaves are given orally five times daily. Lung and non-Hodgkin lymphoma Fresh plant (oral) 0.27
36. Origanum jordanicum Danin & Kunne/Thyme/Za'atar/Pharm-PCT-1729 Lamiaceae Leaves/ About 50 grams of the leaves boiled in 500 ml water; inhale vapor three times daily, five minutes each time. Lung, throat cancer Vapor inhalation 0.15
37. Rosmarinus officinalis L./ Rosemary/ Hasa alban/ Pharm-PCT-2732 Lamiaceae Leaves/ About 20 grams of the leaves boiled in 600 ml water; inhale vapor three times daily, about ten minutes each time. Lung cancer Vapor inhalation 0.10
38. Salvia fruticosa Mill./ Sage/ Maryamya/ Pharm-PCT-2117 Lamiaceae Aerial parts/ Boil about 70 grams from the leaves with 300 ml water, the decoction is to be given four times daily. Colon and liver Decoction (oral) 0.26
39. Salvia palaestina Benth./Kosa’en(kharna) falestini/ Pharm-PCT-2124 Lamiaceae Leaves/ Fifteen grams of the leaves steeped with 100 ml water for 12 hours; 10 ml from this infusion is to be given twice a day. Brain Infusion (oral) 0.19
40. Teucrium capitatum L./ Teucrium/ Ja’da/ Pharm-PCT-2407 Lamiaceae Entire plant/ About 150 grams of the plant boiled for 10 minutes with water; 30 ml from the produced decoction is to be given once daily. Pancreatic and liver Decoction (oral) 0.42
41. Laurus nobilis L. / Bay/ Gaar/ Pharm-PCT-1366 Lauraceae Leaves/ Ten grams from the dried leaves boiled with 100 ml water; 20 ml of this decoction is to be given before meals 3–4 times daily Prostate Decoction (oral) 0.25
42. Alhagi graecorum Boiss./
Camel-thorn/ ala’alook/ Pharm-PCT-65
Leguminosae Fruits/ About 50 grams from the dried fruits boiled in 300 ml water; 10 ml of this decoction is to be given orally twice daily. Glandular Decoction (oral) 0.13
43. Glycine soja Siebold & Zucc./ Soy/ Soya/ Pharm-PCT-2731 Leguminosae Seeds/ About 100 grams of the seeds boiled in 500 ml water; 100 ml of this decoction is to be given orally 5–7 times daily. Breast, ovarian and Hodgkin lymphoma Decoction (oral) 0.19
44. Ononis viscosa subsp. sicula (Guss.) Hub.-Mor./ spiny restharrow/ Shabrak(wassem)/ Pharm-PCT-1686 Leguminosae Entire plant/ About 20–30 grams from the powdered plant boiled in 350 ml water; 10 ml of this decoction is to be given twice daily. Prostate, stomach and breast Decoction (oral) 0.07
45. Linum usitatissimum L./ Flax/ Ketan/ Pharm-PCT-2735 Linaceae Seeds/ Ground Seed (10 grams) are to be given orally three times daily. Ovarian, breast and colon Powder (oral) 0.19
46. Lawsonia inermis L./ Henna / Hena/ Pharm-PCT-2736 Lythraceae Leaves/ A paste from crushed fresh leaves (about 30 grams) are applied externally to affected areas. Skin Paste (topical) 0.22
47. Punica granatum L./ Pomegranate/ Romman/ Pharm-PCT-2730 Lythraceae Fruits (peels)/ About 500 grams of the fruit peels boiled in 1 liter water with 1000 grams sugar; 50 ml of this syrup is to be given twice daily. Colorectal Syrup (oral) 0.27
48. Ficus sycomorus L./ Sycamore Fig / Jomeez/ Pharm-PCT-1030 Moraceae Fruits/ One fresh fruit is boiled with 100 ml syrup for five minute; 20 ml of the syrup is to be given orally 4–6 times daily. Lung Syrup (oral) 0.19
49. Psidium guajava L./ Guava /Juafa/ Pharm-PCT-2720 Myrtaceae Leaves/ A decoction of 100 grams leaves is prepared in one liter water; 2–3 cups are taken orally per day until improvement occurs. Lung and stomach Decoction (oral) 0.19
50. Orobanche aegyptiaca Pers. / Broomrape/ Halook/ Pharm-PCT-1746 Orobanchaceae Roots/ About 500 grams of the ground roots boiled in one liter water for 30 minutes,; 50 ml of this decoction is to be given orally once daily. Ovarian and breast Decoction (oral) 0.21
51. Trifolium philistaeum var. filifolium Zohary/ Palestine Clover/ Barsem/ Pharm-PCT-2493 Papilionaceae Flowers/ About 50 grams of the flowers boiled in 60 ml water; 30 ml of this decoction is to be taken internally twice a day. Ovarian, breast and non Hodgkin lymphoma Decoction (oral) 0.14
52. Plantago lanceolata L./ narrowleaf plantain/ Lesan alhamal/ Pharm-PCT-1887 Plantaginaceae Leaves/ About 500 grams of the leaves boiled in 500 ml water; 100 ml of this decoction is to be taken internally 3–5 times a day. Throat Decoction (oral) 0.29
53. Triticum aestivum L./ Bread wheat/ Kameh/ Pharm-PCT-2540 Poaceae Seeds (husk)/ Powdered seed husks (10 grams) are given orally three times daily. Colon Powder (oral) 0.44
54. Portulaca oleracea L./ Little Hogweed/ Farfahena/ Pharm-PCT-1935 Portulacaceae Aerial parts/ About 100 grams of the plant boiled in 500 ml water; 30 ml of this decoction is to be taken 3–5 times a day. Stomach and esophageal Decoction (oral) 0.47
55. Cyclamen persicum Mill./ Cyclamen/ Sapoon alraa’e/ Pharm-PCT-777 Primulaceae Roots/ Twenty five grams of the ground roots boiled in 350 ml water; 30 ml of this decoction is to be given orally twice daily. Prostate and bladder Decoction (oral) 0.21
56. Nigella arvensis L./ Black cumin / Kezha/ Pharm-PCT-1640 Ranunculaceae Seeds/ About 100 grams of the ground seeds boiled in 330 ml water for 10–15 minutes; this decoction is to be taken 4–5 times daily Lung, brain and skin Decoction (oral) 0.49
57. Ziziphus spina-christi (L.)Desf./ Christ's Thorn Jujube/ Cedar/ Pharm-PCT-2693 Rhamnaceae Flowers/ About 100 grams of the flowers boiled in 500 ml water; 50 ml of this decoction is to be given internally 4–7 times daily. Lung Decoction (oral) 0.31
58. Crataegus azarolus L./ Azarole Hawthorn/ Za’ror/ Pharm-PCT-712 Rosaceae Fruits/ One kilogram of fresh fruit boiled with 1000 ml syrup for 30 minute; 50 ml of the syrup is to be given 5–6 times per day. Lung Syrup (oral) 0.41
59. Galium aparine L./ Stickyweed/ Satoor/ Pharm-PCT-1069 Rubiaceae Leaves/ Fifty grams of the leaves steeped with 100 ml water for one night; 10 ml from this infusion is to be given twice daily. Hodgkin Lymphoma Infusion (oral) 0.11
60. Salix alba L./ White Salix/ Sofsaf abyad/ Pharm-PCT-2093 Salicaceae Bark/ About 60 grams from the plant boiled with 500 ml water for 10 minutes; 50 ml of this decoction is to be given orally each 6 hours. Colon Decoction (oral) 0.19
61. Viscum cruciatum Sieber ex Boiss./ Mistletoe/ hedal/ Pharm-PCT-2662 Santalaceae Leaves/ About 500 grams from the powdered plant boiled with one liter water for 10 minutes; 50 drops of this decoction is to be given three times daily. Esophageal Decoction (oral) 0.51
62. Acer obtusifolium Sm./ Syrian Maple/ Kaikab/ Pharm-PCT-15 Sapindaceae Fruits/ About 500 grams of the fresh fruits boiled with 100 ml water and 100 gram sugar; 20 ml of the resulting syrup is to be given 6–8 times per day. Throat and lung Syrup (oral) 0.21
63. Verbascum sinuatum L./ Mullein/ A’awarwar/ Pharm-PCT-2604 Scrophulariaceae Leaves/ Five grams of the leaves boiled with 150 ml water for 30 minutes; 15 ml of this decoction is to be given orally twice daily. Breast Decoction (oral) 0.59
64. Capsicum annuum L/ Chili pepper/ Shatta/ Pharm-PCT-2729 Solanaceae Fruits/ Four fruits (100 grams) from the plant boiled with 200 ml water for 20 minutes; 5 drops of this decoction is to be given orally each 8 hours. Skin, bladder Decoction (oral) 0.16
65. Lycium europaeum L./ Box thorn/ A’wsaj/ Pharm-PCT-1487 Solanaceae Fruit/ About half kilogram from the fruit boiled with 500 ml water for one hour; 50 ml of this decoction is to be given once daily. Bladder, prostate and breast Decoction (oral) 0.37
66. Mandragora autumnalis Mill./Mandrake/ Tofah almajan/ Pharm-PCT-1509 Solanaceae Fruits/ Ten grams from the plant boiled with100 ml water for 30 minutes, 5 drops of this decoction is to be given twice daily. Lung Decoction (oral) 0.21
67. Withania somnifera (L.) Dunal/ Ashwagandha/ A’eba’b monawem/ Pharm-PCT-2678 Solanaceae Roots/ About 50 grams of the ground roots steeped with 100 ml water for 24 hours; 10 ml from this infusion is to be given twice daily. Esophageal, skin and prostate Infusion (oral) 0.19
68. Camellia sinensis (L.) Kuntze /Green Tea/ Shae akhdar/ Pharm-PCT-2706 Theaceae Leaves/ About 50 grams from the plant boiled with 300 ml water for 10 minutes; this decoction is to be given 6–8 times daily. Breast, lung and ovarian Decoction (oral) 0.31
69. Daphne linearifolia L./ Mezereon/ Mazeryon/ Pharm-PCT-825 Thymelaeaceae Fruits/ A decoction is prepared from 7 to 8 fruits (about 100 grams) boiled in 1 liter water and taken orally, 1 ml two times per day and taken for 14 days. Lung Decoction (oral) 0.04
70. Urtica urens L./ Small Nettle/ Korees harek/ Pharm-PCT-2562 Urticaceae Aerial parts/ About 100–120 grams of the plant boiled with 500 ml water for 30 minutes; 50 ml of the decoction is to be given three times daily. Bones and stomach Decoction (oral) 0.51
71. Curcuma longa L./ Turmeric/ Korkom/ Pharm-PCT-2709 Zingiberaceae Rhizomes/ About 500 grams from the ground dry rhizomes boiled with one liter water for 30 minutes; 300 ml of this decoction is to be given orally three times daily. Prostate, bladder and liver Decoction (oral) 0.53
72. Zingiber officinale Roscoe/ Ginger/ Zangabil/ Pharm-PCT-2724 Zingiberaceae Rhizomes/ About 100 grams of the ground dry rhizomes are boiled in 300 ml water for 10 minutes and given twice daily after meals. Stomach and liver Infusion (oral) 0.51

Data analysis

All citations were placed into ailment categories for each type of cancer. Factor of informant’s consensus (Fic) was employed to indicate how homogenous the information is. In fact, its main use is to select disease categories where there is consensus on the use of plants among the informants. Fic value is close to 0 if plants are chosen randomly, or if informants do not exchange information about their use. High values of Fic (close to 1) occur when there is a well-defined selection criterion in the community and/or if information is frequently exchanged between informants [28].

The Fic is calculated as in the following equation:

Fic=NurNtNur1

Where Nur is the number of use citations in each category and Nt is the number of taxa used.

Fidelity level (Fl) was defined as the ratio between the number of informants who independently suggested the use of a species for the same major purpose and the total number of informants who mentioned the plant for any use. Fl is of equal importance to Fic and it can be calculated according to the following equation:

Fl=NpN*100

Where Np is the number of informants that reported a use of a plant species to treat a particular disease and N is the number of informants that used the plants as a medicine to treat any given disease [29].

The use-value (UV) is a quantitative method that can be used in order to prove the relative importance of species known locally. It is can be calculated according to the following equation:

UVUn

Where UV is the use value of a species; U the number of citations per species; n the number of informants [30].

Results of calculated FIC, Fl and UV are shown in Tables 2, 3 and 4.

Table 3.

Factor of informant’s consensus (Fic) categorized by the types of cancer

Types of cancer Nt Nur Fic
1 Lung 15 350 0.96
2 Colorectal 14 345 0.96
3 Liver 13 364 0.97
4 Skin 13 564 0.98
5 Stomach 11 265 0.96
6 Breast 11 267 0.96
7 Prostate 9 172 0.95
8 Bladder 8 159 0.96
9 Ovarian 6 84 0.94
10 Brain 5 122 0.97
11 Throat 4 74 0.96
12 Kidney 4 96 0.97
13 Esophageal 4 157 0.98
14 Bone 3 194 0.99
15 Hodgkin's lymphoma 2 19 0.94
16 Non-Hodgkin's lymphoma 2 25 0.96
17 Pancreatic 2 57 0.98
18 Spinal cord 1 25 1
19 Gallbladder 1 24 1

Table 4.

Fidelity level of herbal medicines mentioned

Medicinal plant Type of cancer Np N FL,%
Achillea aleppica DC. Colon 13 13 100.00
Alhagi graecorum Boiss. Skin 88 88 100.00
Arbutus andrachne L. Skin 3 3 100.00
Brassica oleracea L. Skin 91 91 100.00
Calotropis procera (Aiton) Dryand. Skin 70 70 100.00
Capparis spinosa L. Skin 79 79 100.00
Catharanthus roseus (L.) G.Don Liver 69 69 100.00
Citrullus colocynthis (L.) Schrad. Bone 71 71 100.00
Colchicum hierosolymitanum L. Bones cancer 71 71 100.00
Crataegus azarolus L. Skin 79 79 100.00
Cucumis sativus L. Liver 16 16 100.00
Daphne linearifolia L. Skin 19 19 100.00
Daucus guttatus Sm. Colon 10 10 100.00
Ficus sycomorus L. Stomach 9 9 100.00
Galium aparine L. Colorectal 17 17 100.00
Hypericum perforatum L. Skin 20 20 100.00
Laurus nobilis L. Brain 8 8 100.00
Lawsonia inermis L. Lung 15 15 100.00
Mandragora officinalis Mill. Brain 28 28 100.00
Mangifera indica L. Prostate 37 37 100.00
Nerium oleander L. Glandular 19 19 100.00
Pistacia palaestina Boiss. Skin 33 33 100.00
Plantago lanceolata L. Colorectal 40 40 100.00
Punica granatum L. Lung 29 29 100.00
Quercus calliprinos Webb Throat 43 43 100.00
Quercus ithaburensis Decne. Colon 66 66 100.00
Rosmarinus officinalis L. Lung 47 47 100.00
Salix alba L. Lung 61 61 100.00
Salvia palaestina Benth. Hodgkin's Lymphoma 16 16 100.00
Sinapis arvensis L. Colon 29 29 100.00
Triticum aestivum L. Esophageal 77 77 100.00
Verbascum sinuatum L. Breast 89 89 100.00
Viscum cruciatum Sieber ex Boiss. Lung 31 31 100.00
Ziziphus spina-christi (L.)Desf. Lung 6 6 100.00
Origanum jordanicum Danin & Kunne Lung 18 23 78.26
Psidium guajava L. Lung 21 29 72.41
Orobanche aegyptiaca Pers. Breast 23 32 71.88
Urtica urens L. Bones 52 77 67.53
Zingiber officinale Roscoe Stomach 52 77 67.53
Arum dioscoridis Sm. Stomach 99 99 66.67
Allium cepa L. Stomach 29 44 65.91
Teucrium capitatum L. Pancreatic 41 63 65.08
Portulaca oleracea L. Esophageal 42 71 59.15
Salvia fruticosa Mill. Colon 23 39 58.97
Melissa officinalis L. Non-Hodgkin's lymphoma 24 41 58.54
Inula viscosa (L.) Aiton Kidney 28 48 58.33
Crocus sativus L. Kidney 39 69 56.52
Acer obtusifolium Sm. Lung 18 32 56.25
Onopordum cynarocephalum subsp. Colon 19 34 55.88
Petroselinum crispum (Mill.) Fuss Kidney 13 24 54.17
Capsicum annuum L Bladder 13 24 54.17
Trifolium philistaeum var. filifolium Zohary Ovarian 11 21 52.38
Annona muricata L. Bladder 25 48 52.08
Ecballium elaterium (L.) A.Rich. Liver 13 25 52.00
Glycine soja Siebold & Zucc. Ovarian 15 29 51.72
Cyclamen persicum Mill. Bladder 16 31 51.61
Cichorium endivia L. Colon 17 33 51.52
Curcuma longa L. Bladder 41 80 51.25

Results and discussion

Traditional herbal medicine knowledge and their utilization by indigenous cultures are not only useful for conservation of biodiversity and cultural traditions but also useful for the population’s healthcare and drug discovery in the present and in the future [31, 32].

Several studies have shown that around 80 % of rural populations in the developing countries consider herbal remedies as integral parts of treatments available. Recently, the use of natural herbal products is increasing in both developed and developing countries due to many reasons [33, 34].

As shown in (Table 1), most of the respondents who work in this field were males. Most of them had educational level equal or higher than high school. In fact about 19.3 % of the total interviewed were university graduates. The table also showed that the majority of respondents were from areas of the West Bank that mostly depend on agriculture or grazing as a mean of income (Jenin, Nablus, Salfeit and Toulkarem). In fact these areas are geographically close to each other (Fig. 1).

Notably the results of this research have revealed that 72 plant species belonging to 44 families were frequently used for treatment of cancer by the 150 herbalists, traditional practitioner healers, rural dwellers and people of the West Bank, Palestine (Table 2).

Echoing our findings in this research, members of the family Compositae and Lamiaceae were the most commonly used as presented in Table 2. The methods of preparation were decoctions (boiling the plants parts in water), infusions (steeping the plants in water for limited time), syrup (boiling the plants with water and sugar (1:1), creams (mixing the plant powders with goat fat or lanolin), paste, fresh juice, ingested entire plant, powder and vapor inhalations. Decoctions and infusions were the most frequently used methods of preparation as presented in Fig. 2.

Fig. 2.

Fig. 2

Frequency of methods of preparation from herbals

Leaves, fruits and seeds were reported to be the most frequently used parts of plants for the treatment of cancer, constituting about 56.9 % of the preparations. This was followed by flowers, aerial parts, entire plants, roots, rhizomes, barks, bulb and stalks as presented in Fig. 3.

Fig. 3.

Fig. 3

Frequency of the used parts of medicinal plants in cancer treatment

The most common cancer type treated with herbal remedies was lung cancer followed by liver, skin, colon and breast cancers as reported in (Fig. 4).

Fig. 4.

Fig. 4

Cancer types treated with herbals in Palestine

This research shows that the medicinal plants still play a role in the care of cancer patients in Palestine. Ephedra alata, Arum dioscoridis, Arum palaestinum were the most commonly used medicinal plants for treatment of cancer and all of these three plants were prepared as decoctions.

However, Ephedra alata were reported to treat three different types of cancer (brain, liver and colon). Accordingly, three Fl values were calculated. The highest one (40.74 %) was for liver cancer. The same consideration can be raised for Arum palaestinum which was reported to treat four different cancers (Liver, colon, kidney and breast). Breast cancer showed the highest Fl value (45.74 %). According to table 4, only Fl values higher than 50 % were included.

In the Mediterranean region and especially in the Holy land (Palestine), the traditional medicine has been highly appreciated and trusted. Many patients go to herbalists or informants to get benefit from this field. Most practitioners are males and this was confirmed in this study; some of them have university degrees. Complementary and alternative medicines are widely used among cancer patients throughout the world. In a previous study from Palestine, 60.9 % of cancer patients reported using medicinal herbs [35]. Medicinal plants utilized in indigenous health traditional system are gradually becoming wiped out due to over utilization, human overpopulation and from other human impact on the environment. The main problem is destructive harvesting of the subterranean parts of the medicinal plants, or even the entire plant.

Medicinal plants maintain the health and vitality of individuals, and may help in treatment of various diseases, including cancer. In this study, some anticancer medicinal plants of foreign origin have been presented. Many of these medicinal plants possess good immunomodulatory and antioxidant properties, which may lead to anticancer activities. The antioxidant phytochemicals protect the cells from oxidative damage. Thus, consuming a diet rich in antioxidant plant foods (e.g. fruits and vegetables) will provide health-protective effects. In 2013, a traditional practitioner living in Jenin claimed that he could cure a cancer patient completely using Ephedra alata. The local media here were interested in this story and many researchers have started working on this plant.

A multidisciplinary approach combining traditional herbal knowledge with pharmaceutical research is a valuable method for identifying potential herbs with possible clinical significance in cancer care [36].

To achieve a positive response to herbal preparations, the proper part of the plant that contains the active constituents should be chosen. It is well known that not all the plant parts contain the same concentration of the active constituents. The other factors to be considered are the harvesting time of the herb (collection time), the soil, the climate conditions, and the method of drying, processing, and extraction [37, 38]. Methods of preparation were mainly decoction and infusion. This is similar to previous studies in our country conducted by Ali-Shtayeh et al., 2011 and Jaradat, 2005 [35, 39]. In an ethnopharmacological survey of medicinal herbs in Golan Heights and the West Bank region performed by Said et al., 2002, only seven plant species were found to treat cancer among 81 species used for treating 115 different ailments and diseases [40]. In another study conducted in the West Bank, Ali-Shtayeh and Rana, 2011, found only 25 plant species used for treatment in cancer without mentioning which type of cancer they can treat [41]. In another study conducted by Ali-Shtayeh et al., 2011, in Palestine, 58 plant species were collected for cancer treatments [35], while in the survey which was conducted by Hudaib et al., 2008 in Jordan, Mujib Nature Reserve and surrounding area, only six plant species were found for treatment of cancer also without mentioning the type of cancer [42].

The methods of preparation mentioned by the informants are not supported by scientific evidence; this could be suitable for some plants but not for the others. In fact, the boiling process can cause severe degradation of the medicinal components in some plants.

The dosage is another concern. To have the expected benefits, the patients should receive a fixed well defined dosage, but in traditional medicine the suitable doses are not clear [37], so studies are needed to determine the concentration of active ingredients depending on their method of preparation to give the suitable recommended doses.

Table 3 shows the Fic values calculated for the categorized cancers. Fic values obtained for the reported cancers indicate the degree of shared knowledge among informants for the treatment of a cancer by certain medicinal plants. Most cancers had high Fic values; however the highest Fic =1 was scored for spinal cord and gallbladder cancers. Fl was 100 % for many plants; the highest UV (0.72) was for Ephedra alata.

Most of the mentioned plants in Table 2 are edible plants and the most of the non-edible plants were used externally. Therefore minor restrictions could be included as they have minor risk compared to the obtained therapeutic benefits from their use for cancer.

Resulting from this information, scientific practical work is in progress on the phytochemical and pharmacological analysis of the plants. This study is important to preserve the knowledge of medicinal plants used by the people of the West Bank regions. Also, it is of significance to utilize new therapeutic natural plant products in various treatments of diseases. Moreover, clinical studies approved according to international guidelines should be considered in order to prove the safety and efficacy of treatment, especially for the most frequently reported medicinal plants.

Conclusion

Many plant species are still used by herbalists and traditional practitioner healers in Palestine for treating various types of cancer. This article provides the knowledge about anticancer medicinal plants of local and foreign origin, which are used by the people all over the Palestinian area in addition to their method of preparation. Many of the used plants have been approved scientifically to have some anticancer activity. A combined scientific effort between informants and the scientific community working in this field may help in the discovery of new anticancer agents. Moreover, scientists may explore the most convenient method of extraction, formulation and dose determination in order to achieve the best benefit from these plants.

Further scientific laboratory studies are required to explore and to investigate the safety and efficacy of these plants, their potential therapeutic effects as well as probable interactions of these medicinal products with conventional anticancer medicines.

Acknowledgements

This study was not funded by any institution. We would like to thank Dr. Cynthia Anderson for her help in language reviewing, all the herbalists and herbal practitioner healers in the West Bank/ Palestine and all participants in the study.

Footnotes

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

Nidal Jaradat conceived, accomplished and designed the study, Rowa Al-Ramahi, Abdel Naser Zaid, Ola Ayesh and Ahmad Mustafa Eid carried out the data obtained and drafted this paper. All researchers collected the data from local herbal practitioners and revised and approved the final manuscript. All authors read and approved the final manuscript.

References

  • 1.Mendelssohn H, Yom-Tov Y. Mammalia of Israel. Fauna Palaestina. Israel Academy of Sciences: Jerusalem; 1999. [Google Scholar]
  • 2.Lev E. Ethno-diversity within current ethno-pharmacology as part of Israeli traditional medicine. J Ethnobiol Ethnomed. 2006;2:2–4. doi: 10.1186/1746-4269-2-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Azaizeh H, Saad B, Khalil K, Said O. The state of the art of traditional Arab herbal medicine in the Eastern region of the Mediterranean: a review. Evid-Based Compl Alt Med. 2006;3:229–235. doi: 10.1093/ecam/nel034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Azaizeh H, Saad B, Cooper E, Said O. Traditional Arabic and Islamic medicine, a re-emerging health aid. Evid-Based Compl Alt Med. 2010;7:419–424. doi: 10.1093/ecam/nen039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Ben-Arye E, Samuels N. Homeopathy on the crossroads of traditional and integrative medicine in the Middle-East. J Med Person. 2015;13:65–71. doi: 10.1007/s12682-014-0196-z. [DOI] [Google Scholar]
  • 6.Saad B, Azaizeh H, Said O. Tradition and perspectives of Arab herbal medicine: a review. Evid Based Complement Alternat Med. 2005;2:475–479. doi: 10.1093/ecam/neh133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Ghorbani A. Clinical and experimental studies on polyherbal formulations for diabetes: current status and future prospective. J Integr Med. 2014;12:336–345. doi: 10.1016/S2095-4964(14)60031-5. [DOI] [PubMed] [Google Scholar]
  • 8.Ehrenreich B, English D. Witches, Midwives, and Nurses: A History of Women Healers (Contemporary Classics) Cuny: Feminist Press; 2010. [Google Scholar]
  • 9.Solecki RS. Shanidar IV, a Neanderthal flower burial in northern Iraq. Science. 1975;190:880–881. doi: 10.1126/science.190.4217.880. [DOI] [Google Scholar]
  • 10.Booker A, Johnston D, Heinrich M. Value chains of herbal medicines—Research needs and key challenges in the context of ethnopharmacology. J Ethnopharmacol. 2012;140:624–633. doi: 10.1016/j.jep.2012.01.039. [DOI] [PubMed] [Google Scholar]
  • 11.Manandhar NP. A survey of medicinal plants of Jajarkot district. Nepal J Ethnopharmacol. 1995;48:1–6. doi: 10.1016/0378-8741(95)01269-J. [DOI] [PubMed] [Google Scholar]
  • 12.Sahoo N, Manchikanti P, Dey S. Herbal drugs: standards and regulation. Fitoterapia. 2010;81:462–471. doi: 10.1016/j.fitote.2010.02.001. [DOI] [PubMed] [Google Scholar]
  • 13.Madhuri S, Pandey G. Some dietary agricultural plants with anticancer properties. Plant Arch. 2008;8:13–16. [Google Scholar]
  • 14.Sivalokanathan S, Ilayaraja M, Balasubramanian M. Efficacy of Terminalia arjuna (Roxb.) on N-nitrosodiethylamine induced hepatocellular carcinoma in rats. Indian J Exp Biol. 2005;43:264–267. [PubMed] [Google Scholar]
  • 15.Pihlak R, Liivand R, Trelin O, Neissar H, Peterson I, Kivistik S, et al. Complementary medicine use among cancer patients receiving radiotherapy and chemotherapy: methods, sources of information and the need for counselling. Eur J Cancer Care. 2014;23:249–254. doi: 10.1111/ecc.12132. [DOI] [PubMed] [Google Scholar]
  • 16.Rosangkima G, Prasad S. Antitumour activity of some plants from Meghalaya and Mizoram against murine ascites Dalton’s lymphoma. Indian J Exp Biol. 2004;42:981–988. [PubMed] [Google Scholar]
  • 17.Ovadje P, Roma A, Steckle M, Nicoletti L, Arnason JT, Pandey S. Advances in the Research and Development of Natural Health Products as Main Stream Cancer Therapeutics. Evid-Based Compl Alt Med. 2015;2015:12. doi: 10.1155/2015/751348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132:1133–1145. doi: 10.1002/ijc.27711. [DOI] [PubMed] [Google Scholar]
  • 19.Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. doi: 10.3322/caac.20107. [DOI] [PubMed] [Google Scholar]
  • 20.Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29. doi: 10.3322/caac.20138. [DOI] [PubMed] [Google Scholar]
  • 21.Jacobson M, Earle CC, Price M, Newhouse JP. How Medicare’s payment cuts for cancer chemotherapy drugs changed patterns of treatment. Health Aff. 2010;1391–9. [DOI] [PubMed]
  • 22.Kathiresan K, Boopathy NS, Kavitha S. Coastal vegetation–an underexplored source of anticancer drugs. Nat Prod Rad. 2006;5:115–119. [Google Scholar]
  • 23.Koduru S, Grierson D, Afolayan A. Ethnobotanical information of medicinal plants used for treatment of cancer in the Eastern Cape Province. South Africa Curr Sci. 2007;92:906–908. [Google Scholar]
  • 24.Wood AJ, Shapiro CL, Recht A. Side effects of adjuvant treatment of breast cancer. N Engl J Med. 2001;344:1997–2008. doi: 10.1056/NEJM200106283442607. [DOI] [PubMed] [Google Scholar]
  • 25.Simoben C, Ibezim A, Ntie-Kang F, Nwodo J, Lifongo L. Exploring Cancer Therapeutics with Natural Products from African Medicinal Plants, Part I: Xanthones, Quinones, Steroids, Coumarins, Phenolics and other Classes of Compounds. Anticancer Agents Med Chem. 2015;15:1092–1111. doi: 10.2174/1871520615666150113110241. [DOI] [PubMed] [Google Scholar]
  • 26.Sharma S, Gupta R. Drug Development from Natural Resource: A Systematic Approach. Mini Rev Med Chem. 2015;15:52–57. doi: 10.2174/138955751501150224160518. [DOI] [PubMed] [Google Scholar]
  • 27.Yesilada E. Contribution of traditional medicine in the healthcare system of the Middle East. Chin Journal Integr Med. 2011;17:95–98. doi: 10.1007/s11655-011-0651-0. [DOI] [PubMed] [Google Scholar]
  • 28.Gazzaneo LRS, De Lucena RFP, de Albuquerque UP. Knowledge and use of medicinal plants by local specialists in an region of Atlantic Forest in the state of Pernambuco (Northeastern Brazil) J Ethnobiol Ethnomed. 2005;1:1–8. doi: 10.1186/1746-4269-1-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Heinrich M, Ankli A, Frei B, Weimann C, Sticher O. Medicinal plants in Mexico: Healers' consensus and cultural importance. Soc Sci Med. 1998;47:1859–1871. doi: 10.1016/S0277-9536(98)00181-6. [DOI] [PubMed] [Google Scholar]
  • 30.Friedman J, Yaniv Z, Dafni A, Palewitch D. A preliminary classification of the healing potential of medicinal plants, based on a rational analysis of an ethnopharmacological field survey among Bedouins in the Negev Desert. Israel J Ethnopharmacol. 1986;16:275–287. doi: 10.1016/0378-8741(86)90094-2. [DOI] [PubMed] [Google Scholar]
  • 31.Kipkore W, Wanjohi B, Rono H, Kigen G. A study of the medicinal plants used by the Marakwet Community in Kenya. J Ethnobiol Ethnomed. 2014;10:24–28. doi: 10.1186/1746-4269-10-24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Orhan IE. Pharmacognosy: Science of natural products in drug discovery. Bioimpacts. 2014;4:109–110. doi: 10.15171/bi.2014.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Li L, Zhou X, Li N, Sun M, Lv J, Xu Z. Herbal drugs against cardiovascular disease: traditional medicine and modern development. Drug Discov Today. 2015;20:1074–1086. doi: 10.1016/j.drudis.2015.04.009. [DOI] [PubMed] [Google Scholar]
  • 34.Lanzotti V. Drugs based on natural compounds: recent achievements and future perspectives. Phytochem Rev. 2014;13:725–726. doi: 10.1007/s11101-014-9385-x. [DOI] [Google Scholar]
  • 35.Ali-Shtayeh MS, Jamous RM, Jamous RM. Herbal preparation use by patients suffering from cancer in Palestine. Complement Ther Clin Pract. 2011;17:235–240. doi: 10.1016/j.ctcp.2011.06.002. [DOI] [PubMed] [Google Scholar]
  • 36.Ben-Arye E, Schiff E, Hassan E, Mutafoglu K, Lev-Ari S, Steiner M, et al. Integrative oncology in the Middle East: from traditional herbal knowledge to contemporary cancer care. Ann Onco. 2012;23:211–221. doi: 10.1093/annonc/mdr054. [DOI] [PubMed] [Google Scholar]
  • 37.Alzweiri M, Sarhan AA, Mansi K, Hudaib M, Aburjai T. Ethnopharmacological survey of medicinal herbs in Jordan, the Northern Badia region. J Ethnopharmacol. 2011;137:27–35. doi: 10.1016/j.jep.2011.02.007. [DOI] [PubMed] [Google Scholar]
  • 38.Seid MA, Tsegay BA. Ethnobotanical survey of traditional medicinal plants in Tehuledere district, South Wollo. Ethiopia J Med Plants Res. 2011;5:6233–6242. [Google Scholar]
  • 39.Jaradat N. Ethnopharmacological survey of natural products in palestine. An-Najah Univ J Res. 2005;19.
  • 40.Said O, Khalil K, Fulder S, Azaizeh H. Ethnopharmacological survey of medicinal herbs in Israel, the Golan Heights and the West Bank region. J Ethnopharmacol. 2002;83:251–265. doi: 10.1016/S0378-8741(02)00253-2. [DOI] [PubMed] [Google Scholar]
  • 41.Ali-Shtayeh MS, Jamous RM. Herbal medicines in cancer care in the Palestinian Authority. Eur J Integr Med. 2011;3:125–131. doi: 10.1016/j.eujim.2011.05.049. [DOI] [Google Scholar]
  • 42.Hudaib M, Mohammad M, Bustanji Y, Tayyem R, Yousef M, Abuirjeie M, et al. Ethnopharmacological survey of medicinal plants in Jordan, Mujib Nature Reserve and surrounding area. J Ethnopharmacol. 2008;120:63–71. doi: 10.1016/j.jep.2008.07.031. [DOI] [PubMed] [Google Scholar]

Articles from BMC Complementary and Alternative Medicine are provided here courtesy of BMC

RESOURCES